EYE Summary (August 2024): Incredibly Undervalued, page-151

I would not invest in this company unless I saw a marked improvement. It is unprofitable, appears to be short of capital, has few assets and is reliant upon sales in a highly competitive industry. Raising capital is dilutionary and causes retail investors grief. It has a good product being sold and another speculative one which has been patented, not yet certified for use and will cost a small fortune to get to market. It last reported in December and raised capital in March, since then - nothing.

Balanced against that is TheAnalyst007's constant urging to buy cheap shares, at the same time trying to discredit anybody discussing the real position. He does it often in other stocks and he has a terrible track record pumping because he doesn't understand financials, nor does he has a licence to give financial advice. Nor do I, but I don't give advice, I discuss the facts relating to stocks. The information he puts forward can often be easily and quickly discredited. He is a BS artist.

Here he said that ZIP is profitable. Fabricated. Forget about the stupid price prediction.





Part of his constant pumping and ramping of Cettire $2.52 to $1.38





DRO $2.50 to $1.14